Precision genome editing: A small revolution for glycobiology

Glycobiology

Volumn 24, Issue 8, 2014, Pages 663-680

  Steentoft, Catharina ^a   Bennett, Eric P ^a   Schjoldager, Katrine T B G ^a   Vakhrushev, Sergey Y ^a   Wandall, Hans H ^a   Clausen, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

GALNT; Glycoengineering; Isogenic cell system; Simple Cell

Indexed keywords

CADHERIN; ENDONUCLEASE; FOKI ENDONUCLEASE; GLYCAN; GLYCOGEN; GLYCOPROTEIN; HOMING ENDONUCLEASE; NUCLEASE; O GLYCOPROTEOME; PROTEOME; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE;

CELL INTERACTION; CHO CELL LINE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COLLISIONALLY ACTIVATED DISSOCIATION; CONGENITAL DISORDER OF GLYCOSYLATION; CYTOTOXICITY; DIMERIZATION; DNA BINDING; DNA END JOINING REPAIR; DNA MODIFICATION; DNA SEQUENCE; DOUBLE STRANDED DNA BREAK; GENE DELETION; GENE DISRUPTION; GENE INACTIVATION; GENE INSERTION; GENE MODIFICATION; GENE SEQUENCE; GENE TARGETING; GENOME; GENOME EDITING; GLYCOBIOLOGY; HAPLOIDY; HOMODIMERIZATION; MISSENSE MUTATION; NONHUMAN; OFF TARGET EFFECT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; SINGLE STRANDED DNA BREAK; XENOTRANSPLANTATION; ANIMAL; GENETIC ENGINEERING; GENETICS; PROCEDURES;

ANIMALS; GENETIC ENGINEERING; GENOME; GLYCOMICS;

EID: 84903703251     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu046     Document Type: Review

References (196)

1. Aagaard L, Rossi JJ. 2007. RNAi therapeutics: Principles, prospects and challenges. Adv Drug Deliv Rev. 59: 75-86. (Pubitemid 46770900
2. Almeida R, Levery SB, Mandel U, Kresse H, Schwientek T, Bennett EP, Clausen H. 1999. Cloning and expression of a proteoglycan UDP-galactose: β-xylose β1, 4-galactosyltransferase I. J Biol Chem. 274: 26165-26171
3. Amado M, Almeida R, Schwientek T, Clausen H. 1999. Identifcation and characterization of large galactosyltransferase gene families: Galactosyltransferases for all functions 1. Biochim Biophys Acta. 1473: 35-53
4. Bedell VM, Wang Y, Campbell JM, Poshusta TL, Starker CG, Krug RG, TanW, Penheiter SG, Ma AC, Leung AYH, et al. 2012. In vivo genome editing using a high-efficiency TALEN system. Nature. 491: 114-118
5. Bennett EP, Mandel U, Clausen H, Gerken T, Fritz T, Tabak L. 2012. Control of mucin-Type O-glycosylation: A classification of the polypeptide GalNAc-Transferase gene family. Glycobiology. 22: 736-756
6. Betting DJ, Mu XY, Kafi K, McDonnel D, Rosas F, Gold DP, Timmerman JM. 2009. Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells. Vaccine. 27: 250-259
7. Beurdeley M, Bietz F, Li J, Thomas S, Stoddard T, Juillerat A, Zhang F, Voytas DF, Duchateau P, Silva GH. 2013. Compact designer TALENs for efficient genome engineering. Nat Commun. 4: 1762-1768
8. Bhakta MS, Segal DJ. 2010. The generation of zinc finger proteins by modular assembly. In: Mackay JP, Segal DJ, editors. Engineered Zinc Finger Proteins, Methods in Molecular Biology. New York: Springer. p. 3-30
9. Bibikova M, Beumer K, Trautman JK, Carroll D. 2003. Enhancing gene targeting with designed zinc finger nucleases. Science. 300: 764. (Pubitemid 36532104
10. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. 2009. Breaking the code of DNA binding specificity of TAL-Type III effectors. Science. 326: 1509-1512
11. Bogdanove AJ, Voytas DF. 2011. TAL effectors: Customizable proteins for DNA targeting. Science. 333: 1843-1846
12. Boissel S, Jarjour J, Astrakhan A, Adey A, Gouble A, Duchateau P, Shendure J, Stoddard BL, Certo MT, Baker D, et al. 2013. megaTALs: A rare-cleaving nuclease architecture for therapeutic genome engineering. Nucleic Acids Res. 42: 2591-2601
13. Briggs AW, Rios X, Chari R, Yang L, Zhang F, Mali P, Church GM. 2012. Iterative capped assembly: Rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res. 40: E117
14. Carbery ID, Ji D, Harrington A, Brown V, Weinstein EJ, Liaw L, Cui X. 2010. Targeted genome modification in mice using zinc-finger nucleases. Genetics. 186: 451-459
15. Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M. 2012. Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA. 109: 17382-17387
16. Carroll D. 2014. Genome engineering with targetable nucleases. Annu Rev Biochem. 83: Epub
17. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 39: E82
18. Chalkley RJ, Thalhammer A, Schoepfer R, Burlingame AL. 2009. Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides. Proc Natl Acad Sci USA. 106: 8894-8899
19. Chen F, Pruett-Miller SM, Huang Y, Gjoka M, Duda K, Taunton J, Collingwood TN, Frodin M, Davis GD. 2011. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods. 8: 753-755
20. Chen G, Qian H, Starzl T, Sun H, Garcia B, Wang X, Wise Y, Liu Y, Xiang Y, Copeman L, et al. 2005. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med. 11: 1295-1298. (Pubitemid 41752909
21. Chen Z, Jaafar L, Agyekum DG, Xiao H, Wade MF, Kumaran RI, Spector DL, Bao G, Porteus MH, Dynan WS, et al. 2013. Receptor-mediated delivery of engineered nucleases for genome modification. Nucleic Acids Res. 41: E182
22. Chen W, Stanley P. 2003. Five Lec1 CHO cell mutants have distinct Mgat1 gene mutations that encode truncated N-Acetylglucosaminyltransferase I. Glycobiology. 13: 43-50. (Pubitemid 36372514
23. Cho SW, Kim S, Kim JM, Kim J-S. 2013. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol. 31: 230-232
24. Cho SW, Kim S, Kim Y, Kweon J, Kim HS, Bae S, Kim J-S. 2014. Analysis of off-Target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 24: 132-141
25. Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF. 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics. 186: 757-761
26. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/ Cas systems. Science. 339: 819-823
27. Cost GJ, Freyvert Y, Vafiadis A, Santiago Y, Miller JC, Rebar E, Collingwood TN, Snowden A, Gregory PD. 2010. BAK and BAX deletion using zincfinger nucleases yields apoptosis-resistant CHO cells. Biotechnol Bioeng. 105: 330-340
28. Cradick TJ, Fine EJ, Antico CJ, Bao G. 2013. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-Target activity. Nucleic Acids Res. 41: 9584-9592
29. Cristea S, Freyvert Y, Santiago Y, Holmes MC, Urnov FD, Gregory PD, Cost GJ. 2013. In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol Bioeng. 110: 871-880
30. Daboussi F, Zaslavskiy M, Poirot L, Loperfido M, Gouble A, Guyot V, Leduc S, Galetto R, Grizot S, Oficjalska D, et al. 2012. Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases. Nucleic Acids Res. 40: 6367-6379
31. Dahlem TJ, Hoshijima K, Jurynec MJ, Gunther D, Starker CG, Locke AS, Weis AM, Voytas DF, Grunwald DJ. 2012. Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome. PLoS Genet. 8: E1002861
32. Darula Z, Chalkley RJ, Baker P, Burlingame AL, Medzihradszky KF. 2010. Mass spectrometric analysis, automated identification and complete annotation of O-linked glycopeptides. Eur J Mass Spectrom. 16: 421-428
33. Darula Z, Medzihradszky KF. 2009. Affinity enrichment and characterization of mucin core-1 type glycopeptides from bovine serum. Mol Cell Proteomics. 8: 2515-2526
34. Ding Q, Lee Y-K, Schaefer EAK, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT, et al. 2013. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell. 12: 238-251
35. Do KY, Cummings RD. 1993. 2, 6-branched mannose and the regulation of poly-N-Acetyllactosamine biosynthesis in N-linked oligosaccharides of Chinese hamster ovary cells. J Biol Chem. 268: 22028-22035. (Pubitemid 23320711
36. Dorsett Y, Tuschl T. 2004. siRNAs: Applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov. 3: 318-329. (Pubitemid 38499759
37. Doyon Y, Choi VM, Xia DF, Vo TD, Gregory PD, Holmes MC. 2010. Transient cold shock enhances zinc-finger nuclease-mediated gene disruption. Nat Methods. 7: 459-460
38. Duda K, Lonowski LA, Kofoed-Nielsen M, Ibarra A, Delay CM, Kang Q, Yang Z, Pruett-Miller SM, Bennett EP, Wandall HH, et al. 2014. High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs. Nucleic Acids Res. Epub
39. Edgell DR ed. 2014. Homing endonucleases Y methods and protocols. In: Edgell DR, editor. Methods in Molecular Biology. New York: Springer
40. Editorial. 2011. Method of the Year 2011. Nat Methods. 9: 1-1
41. Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM. 2013. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods. 10: 1116-1121
42. Fan L, Kadura I, Krebs LE, Hatfield CC, Shaw MM, Frye CC. 2012. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. Biotechnol Bioeng. 109: 1007-1015
43. Feng Y, Zhang S, Huang X. 2014. A robust TALENs system for highly efficient mammalian genome editing. Sci Rep. 4: 3632
44. Foley JE, Maeder ML, Pearlberg J, Joung JK, Peterson RT, Yeh J-RJ. 2009. Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. Nat Protoc. 4: 1855-1867
45. Freeze HH. 2013. Understanding human glycosylation disorders: Biochemistry leads the charge. J Biol Chem. 288: 6936-6945
46. Freire-de-lima L, Gelfenbeyn K, Ding Y, Mandel U, Clausen H, Handa K. 2011. Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc Natl Acad Sci USA. 108: 17690-17695
47. Fu Y, Foden Ja, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. 2013. High-frequency off-Target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 31: 822-826
48. Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol. 32: 279-284
49. Fuster MM, Esko JD. 2005. The sweet and sour of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer. 5: 526-542. (Pubitemid 40942829
50. Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P, Kaeppel C, Nowrouzi A, Bartholomae CC, Wang J, Friedman G, et al. 2011. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol. 29: 816-823
51. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas III CF. 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods. 9: 805-809
52. Galili U. 2001. The α-Gal epitope (Galα1-3Galβ1-4GlcNAc- R) in xenotransplantation. Biochimie. 83: 557-563
53. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Jeffrey C, Choi VM, Jenkins SS, Wood A, Cui X, Meng X, et al. 2009. Knockout rats produced using designed zinc finger nucleases. Science. 325: 433
54. Gottlieb C, Baenziger J, Kornfeld S. 1975. Deficient uridine diphosphate-N-Acetylglucosamine: Glycoprotein Activity in a clone of Chinese Hamster Ovary cells with altered surface glycoproteins. J Biol Chem. 250: 3303-3309
55. Guilinger JP, Pattanayak V, Reyon D, Tsai SQ, Sander JD, Joung JK, Liu DR. 2014. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods. 11: 429-435
56. Guschin DY, Waite AJ, Katibah GE, Miller JC, Holmes MC, Rebar EJ. 2010. A rapid and general assay for monitoring endogenous gene modificationeered zinc finger proteins. Methods Mol Biol. 649: 247-256
57. Hafez M, Hausner G. 2012. Homing endonucleases: DNA scissors on a mission. Genome. 55: 553-569
58. Haltiwanger RS, Blomberg MA, Hart GW. 1992. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-Acetylglucosamine: Polypeptide beta-N-Acetylglucosaminyltransferase. J Biol Chem. 267: 9005-9013
59. Haltiwanger RS, Lowe JB. 2004. Role of glycosylation in development. Annu Rev Biochem. 73: 491-537. (Pubitemid 39050378
60. Händel E-M, Alwin S, Cathomen T. 2009. Expanding or restricting the target site repertoire of zinc-finger nucleases: The inter-domain linker as a major determinant of target site selectivity. Mol Ther. 17: 104-111
61. Hauschild J, Petersen B, Santiago Y, Queisser A-L, Carnwath JW, Lucas-Hahn A, Zhang L, Meng X, Gregory PD, Schwinzer R, et al. 2011. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci USA. 108: 12013-12017
62. Hisano Y, Ota S, Arakawa K, Muraki M, Kono N, Oshita K, Sakuma T, Tomita M, Yamamoto T, Okada Y, et al. 2013. Quantitative assay for TALEN activity at endogenous genomic loci. Biol Open. 2: 363-367
63. Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, Katibah GE, Amora R, Boydston EA, Zeitler B, et al. 2009. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zincfinger nucleases. Nat Biotechnol. 27: 851-857
64. Hogan JM, Pitteri SJ, Chrisman Pa, McLuckey Sa. 2005. Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation. J Proteome Res. 4: 628-632. (Pubitemid 40548173
65. Hossler P, Khattak SF, Li ZJ. 2009. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 19: 936-949
66. Hou Z, Zhang Y, Propson NE, Howden SE, Chu L-F, Sontheimer EJ, Thomson JA. 2013. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA. 110: 15644-15649
67. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, et al. 2013. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 31: 827-832
68. Huertas P. 2010. DNA resection in eukaryotes: Deciding how to fix the break. Nat Struct Mol Biol. 17: 11-16
69. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K, Narimatsu H. 2005. Core 3 synthase is downregulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci USA. 102: 4572-4577. (Pubitemid 40397153
70. Jackson AL, Linsley PS. 2010. Recognizing and avoiding siRNA off-Target effects for target identification and therapeutic application. Nat Rev Drug Discov. 9: 57-67
71. Jae LT, Raaben M, Riemersma M, van Beusekom E, Blomen VA, Velds A, Kerkhoven RM, Carette JE, Topaloglu H, Meinecke P, et al. 2013. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science. 340: 479-483
72. Jenkins N, Parekh RB, James DC. 1996. Getting the glycosylation right: Implications for the biotechnology industry. Nat Biotechnol. 14: 975-981. (Pubitemid 26286569
73. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 337: 816-821
74. Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. 2013. RNA-programmed genome editing in human cells. Elife. 2: E00471
75. Joung JK, Sander JD. 2012. TALENs: Awidely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol. 14: 49-55
76. Ju T, Cummings RD. 2002. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA. 99: 16613-16618. (Pubitemid 36034021
77. Kato K, Jeanneau C, Tarp MA, Benet-Pagès A, Lorenz-Depiereux B, Bennett EP, Mandel U, Strom TM, Clausen H. 2006. Polypeptide GalNAc-Transferase T3 and familial tumoral calcinosis. J Biol Chem. 281: 18370-18377
78. Kim YG, Cha J, Chandrasegaran S. 1996. Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA. 93: 1156-1160. (Pubitemid 26052857
79. Kim E, Kim S, Kim DH, Choi B-S, Choi I-Y, Kim J-S. 2012. Precision genome engineering with programmable DNA-nicking enzymes. Genome Res. 22: 1327-1333
80. Kim H, Kim M-S, Wee G, Lee C-I, Kim H, Kim J-S. 2013. Magnetic separation and antibiotics selection enable enrichment of cells with ZFN/TALENinduced mutations. PLoS ONE. 8: E56476
81. Kim H, Um E, Cho S-R, Jung C, Kim H, Kim J-S. 2011. Surrogate reporters for enrichment of cells with nuclease-induced mutations. Nat Methods. 8: 941-943
82. Kingsley DM, Kozarsky KF, Hobbie L, Krieger M. 1986. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/ UDP-GalNAc 4-epimerase deficient mutant. Cell. 44: 749-759. (Pubitemid 16073971
83. Kingsley DM, Krieger M. 1984. Receptor-mediated endocytosis of low density lipoprotein: Somatic cell mutants define multiple genes required for expression of surface-receptor activity. Proc Natl Acad Sci USA. 81: 5454-5458. (Pubitemid 14000505
84. Kleinstiver BP, Wolfs JM, Kolaczyk T, Roberts AK, Hu SX, Edgell DR. 2012. Monomeric site-specific nucleases for genome editing. Proc Natl Acad Sci USA. 109: 8061-8066
85. Koike-Yusa H, Li Y, Tan E-P, Velasco-Herrera MDC, Yusa K. 2014. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol. 32: 267-273
86. Kozarsky K, Kingsley D, Krieger M. 1988. Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. Proc Natl Acad Sci USA. 85: 4335-4339
87. Kuwaki K, Tseng Y, Dor FJMF, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, et al. 2005. Heart transplantation in baboons using α1, 3-galactosyl transferase gene-knockout pigs as donors: Initial experience. Nat Med. 11: 29-31. (Pubitemid 40215833
88. Lamb BM, Mercer AC, Barbas CF. 2013. Directed evolution of the TALE N-Terminal domain for recognition of all 5′ bases. Nucleic Acids Res. 41: 9779-9785
89. Lee HJ, Kim E, Kim J-S. 2010. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res. 20: 81-89
90. Lehle L, Strahl S, Tanner W. 2006. Protein glycosylation, conserved from yeast to man: A model organism helps elucidate congenital human diseases. Angew Chemie. 45: 6802-6818. (Pubitemid 44654465
91. Lewis NE, Liu X, Li Y, Nagarajan H, Yerganian G, O'Brien E, Bordbar A, Roth AM, Rosenbloom J, Bian C, et al. 2013. Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. Nat Biotechnol. 31: 759-765
92. Li P, Estrada JL, Burlak C, Tector AJ. 2012. Biallelic knockout of the α-1, 3 galactosyltransferase gene in porcine liver-derived cells using zinc finger nucleases. J Surg Res. 181: E39-e45
93. Liu J, Gaj T, Patterson JT, Sirk SJ, Barbas III CF 2014. Cell-penetrating peptidemediated delivery of TALEN proteins via bioconjugation for genome engineering. PLoS ONE. 9: E85755
94. Lommel M, Winterhalter PR, Willer T, Dahlhoff M, Schneider MR, Bartels MF, Renner-Müller I, Ruppert T, Wolf E, Strahl S. 2013. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc Natl Acad Sci USA. 110: 21024-21029
95. Lowe JB, Marth JD. 2003. A genetic approach to mammalian glycan function. Annu Rev Biochem. 72: 643-691. (Pubitemid 36930456
96. Maeda Y, Ashida H, Kinoshita T. 2006. CHO glycosylation mutants: GPI anchor. Methods Enzymol. 416: 182-205. (Pubitemid 44750111
97. Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RJ, Townsend JA, et al. 2008. Rapid open-source engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell. 31: 294-301
98. Maeder ML, Thibodeau-Beganny S, Sander JD, Voytas DF, Joung JK. 2009. Oligomerized pool engineering (OPEN): An open-source protocol for making customized zinc-finger arrays. Nat Protoc. 4: 1471-1501
99. Maier DA, Brennan AL, Jiang S, Binder-Scholl GK, Lee G, Plesa G, Zheng Z, Cotte J, Carpenito C, Wood T, et al. 2013. Efficient clinical scale gene modification via zinc finger nuclease-Targeted disruption of the HIV co-receptor CCR5. Hum Gene Ther. 14: 1-14
100. Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Horvath P, Moineau S, Mojica FJM, Wolf YI, Yakunin AF, et al. 2011. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol. 9: 467-477
101. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM. 2013. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 31: 833-838
102. Mali P, Esvelt KM, Church GM. 2013. Cas9 as a versatile tool for engineering biology. Nat Methods. 10: 957-963
103. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science. 339: 823-826
104. Malphettes L, Freyvert Y, Chang J, Liu P-Q, Chan E, Miller JC, Zhou Z, Nguyen T, Tsai C, Snowden AW, et al. 2010. Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng. 106: 774-783
105. Maresca M, Lin VG, Guo N, Yang Y. 2013. Obligate ligation-gated recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res. 23: 539-546
106. Meckler JF, Bhakta MS, Kim M-S, Ovadia R, Habrian CH, Zykovich A, Yu A, Lockwood SH, Morbitzer R, Elsäesser J, et al. 2013. Quantitative analysis of TALE-DNA interactions suggests polarity effects. Nucleic Acids Res. 41: 4118-4128
107. Metzger MJ, McConnell-Smith A, Stoddard BL, Miller AD. 2011. Singlestrand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res. 39: 926-935
108. Miller JC, Holmes MC, Wang J, Guschin DY, Lee Y-LL, Rupniewski I, Beausejour CM, Waite AJ, Wang NS, Kim KA, et al. 2007. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol. 25: 778-785. (Pubitemid 47052191
109. Miller JC, Tan SY, Qiao GJ, Barlow KA, Wang JB, Xia DF, Meng XD, Paschon DE, Leung E, Hinkley SJ, et al. 2011. ATALE nuclease architecture for efficient genome editing. Nat Biotechnol. 29: 143-148
110. Miwa HE, Gerken TA, Jamison O, Tabak LA. 2010. Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-Acetylgalactosaminyltransferase-1. J Biol Chem. 285: 1208-1219
111. Moehle EA, Rock JM, Lee Y-L, Jouvenot Y, DeKelver RC, Gregory PD, Urnov FD, Holmes MC. 2007. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA. 104: 3055-3060. (Pubitemid 46364112
112. Moremen KW, Tiemeyer M, Nairn AV. 2012. Vertebrate protein glycosylation: Diversity, synthesis and function. Nat Rev Mol Cell Biol. 13: 448-462
113. Moscou MJ, Bogdanove AJ. 2009. Recognition by TAL effectors. Science. 326: 1501
114. Mussolino C, Cathomen T. 2012. TALE nucleases: Tailored genome engineering made easy. Curr Opin Biotechnol. 23: 644-650
115. Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T, Cathomen T. 2011. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res. 39: 9283-9293
116. Narimatsu H. 2006. Human glycogene cloning: Focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. Curr Opin Struct Biol. 16: 567-575. (Pubitemid 44466414
117. Nettleship JE, Assenberg R, Diprose JM, Rahman-Huq N, Owens RJ. 2010. Recent advances in the production of proteins in insect and mammalian cells for structural biology. J Struct Biol. 172: 55-65
118. North SJ, Huang H-H, Sundaram S, Jang-Lee J, Etienne AT, Trollope A, Chalabi S, Dell A, Stanley P, Haslam SM. 2010. Glycomics profiling of Chinese Hamster Ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity. J Biol Chem. 285: 5759-5775
119. O'Neill RA. 1996. Enzymatic release of oligosaccharides from glycoproteins for chromatographic and electrophoretic analysis. J Chromatogr A. 720: 201-215. (Pubitemid 26037616
120. Orlando SJ, Santiago Y, DeKelver RC, Freyvert Y, Boydston EA, Moehle EA, Choi VM, Gopalan SM, Lou JF, Li J, et al. 2010. Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res. 38: E152
121. Osborn MJ, Starker CG, McElroy AN, Webber BR, Riddle MJ, Xia L, DeFeo AP, Gabriel R, Schmidt M, Von Kalle C, et al. 2013. TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 21: 1151-1159
122. Ousterout DG, Perez-Pinera P, Thakore PI, Kabadi AM, Brown MT, Qin X, Fedrigo O, Mouly V, Tremblay JP, Gersbach CA. 2013. Reading frame correction by targeted genome editing restores dystrophin expression in cells from duchenne muscular dystrophy patients. Mol Ther. 21: 1718-1726
123. Park J, Katagiri T, Chung S, Kijima K, Nakamura Y. 2011. Polypeptide N-Acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin. Neoplasia. 13: 320-326
124. Park J-H, Nishidate T, Kijima K, Ohashi T, Takegawa K, Fujikane T, Hirata K, Nakamura Y, Katagiri T. 2010. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-Acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res. 70: 2759-2769
125. Patnaik SK, Stanley P. 2006. Lectin-resistant CHO glycosylation mutants. Methods Enzymol. 416: 159-182. (Pubitemid 44750110
126. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. 2013. Highthroughput profiling of off-Target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 31: 839-843
127. Pattanayak V, Ramirez CL, Joung JK, Liu DR. 2011. Revealing off-Target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods. 8: 765-770
128. Pedersen NB, Wang S, Narimatsu Y, Yang Z, Halim A, Schjoldager K.T.-B.G, Madsen TD, Seidah NG, Bennett EP, Levery SB, et al. 2014. Low-density lipoprotein receptor class A repeats are O-glycosylated in linker regions. J Biol Chem. Epub
129. Pelascini LPL, Maggio I, Liu J, Holkers M, Cathomen T, Gonçalves MaFV. 2013. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases. Hum Gene Ther Methods. 24: 399-411
130. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee Y-L, et al. 2008. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol. 26: 808-816. (Pubitemid 351961450
131. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen S-H, Ball S, Specht SM, Polejaeva IA, Monahan JA, et al. 2003. Production of alpha 1, 3-galactosyltransferase-deficient pigs. Science. 299: 411-414
132. Pratt J, Venkatraman N, Brinker A, Xiao Y, Blasberg J, Thompson DC, Bourner M. 2012. Use of zinc finger nuclease technology to knock out efflux transporters in C2BBe1 cells. Curr Protoc Toxicol. Chapter 23: Unit 23.2.1-23.2.22
133. Pruett-Miller SM, Reading DW, Porter SN, Porteus MH. 2009. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet. 5: E1000376
134. Rahman SH, Bobis-Wozowicz S, Chatterjee D, Gellhaus K, Pars K, Heilbronn R, Jacobs R, Cathomen T. 2012. The nontoxic cell cycle modulator indirubin augments transduction of adeno-Associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum Gene Ther. 24: 67-77
135. Ramakrishna S, Cho SW, Kim S, Song M, Gopalappa R, Kim J-S, Kim H. 2014. Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations. Nat Commun. 5: 1-10
136. Ramakrishna S, Kim Y-H, Kim H. 2013. Stability of zinc finger nuclease protein is enhanced by the proteasome inhibitor MG132. PLoS ONE. 8: E54282
137. Ramirez CL, Certo MT, Mussolino C, Goodwin MJ, Cradick TJ, McCaffrey AP, Cathomen T, Scharenberg AM, Joung JK. 2012. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res. 40: 5560-5568
138. Ramirez CL, Foley JE, Wright DA, Müller-Lerch F, Rahman SH, Cornu TI, Winfrey RJ, Sander JD, Fu F, Townsend JA, et al. 2008. Unexpected failure rates for modular assembly of engineered zinc fingers. Nat Methods. 5: 374-375. (Pubitemid 351619087
139. Ran FA, Hsu PD, Lin C-Y, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, et al. 2013. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 154: 1380-1389
140. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. 2013. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 8: 2281-2308
141. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. 2012. FLASH assembly of TALENs for high-Throughput genome editing. Nat Biotechnol. 30: 460-465
142. Rita Costa a, Elisa Rodrigues M, Henriques M, Azeredo J, Oliveira R. 2010. Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm. 74: 127-138
143. Rouet P, Smih F, Jasin M. 1994. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci USA. 91: 6064-6068. (Pubitemid 24188283
144. Sakuma T, Ochiai H, Kaneko T, Mashimo T, Tokumasu D, Sakane Y, Suzuki K-I, Miyamoto T, Sakamoto N, Matsuura S, et al. 2013. Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity. Sci Rep. 3: 3379
145. Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, Curtin SJ, Blackburn JS, Thibodeau-Beganny S, Qi Y, et al. 2011. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods. 8: 67-69
146. Sander JD, Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 32: 347-355
147. Santiago Y, Chan E, Liu PQ, Orlando S, Zhang L, Urnov FD, Holmes MC, Guschin D, Waite A, Miller JC, et al. 2008. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA. 105: 5809-5814. (Pubitemid 351758454
148. Schierling B, Dannemann N, Gabsalilow L, Wende W, Cathomen T, Pingoud A. 2012. A novel zinc-finger nuclease platform with a sequence-specific cleavage module. Nucleic Acids Res. 40: 2623-2638
149. Schjoldager K.T.-B.G, Clausen H. 2012. Site-specific protein O-glycosylation modulates proprotein processing-deciphering specific functions of the large polypeptide GalNAc-Transferase gene family. Biochim Biophys Acta. 1820: 2079-2094
150. Schjoldager K.T.-B.G, Vakhrushev SY, Kong Y, Steentoft C, Nudelman AS, Pedersen NB, Wandall HH, Mandel U, Bennett EP, Levery SB, et al. 2012. Probing isoform-specific functions of polypeptide GalNAc-Transferases using zinc finger nuclease glycoengineered SimpleCells. Proc Natl Acad Sci USA. 109: 9893-9898
151. Schjoldager K.T.-B.G, Vester-Christensen MB, Bennett EP, Levery SB, Schwientek T, Yin W, Blixt O, Clausen H. 2010. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: Possible role of polypeptide GalNAc-Transferase-2 in regulation of concentrations of plasma lipids. J Biol Chem. 285: 36293-36303
152. Schjoldager K.T.-B.G, Vester-Christensen MB, Goth CK, Petersen TN, Brunak S, Bennett EP, Levery SB, Clausen H. 2011. A systematic study of site-specific GalNAc-Type O-glycosylation modulating proprotein convertase processing. J Biol Chem. 286: 40122-40132
153. Schmid-Burgk JL, Schmidt T, Kaiser V, Höning K, Hornung V. 2013. A ligation-independent cloning technique for high-Throughput assembly of transcription activator-like effector genes. Nat Biotechnol. 31: 76-81
154. Sealover NR, Davis A, Brooks JK, George HJ, Kayser KJ, Lin N. 2013. Engineering Chinese Hamster Ovary (CHO) cells for producing recombinant proteins with simple glycoforms by zinc-finger nuclease (ZFN) Y mediated gene knockout of mannosyl (alpha-1, 3-)-glycoprotein beta-1, 2-N-Acetylglucosaminyltransferase (Mgat1). J Biotechnol. 167: 24-32
155. Segal DJ, Meckler JF. 2013. Genome engineering at the dawn of the golden age. Annu Rev Genomics Hum Genet. 14: 135-158
156. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench GJ, et al. 2013. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 31: 827-832
157. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SHA, Presta LG. 2002. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem. 277: 26733-26740. (Pubitemid 34951677
158. Shimizu Y, Bhakta MS, Segal DJ. 2009. Restricted spacer tolerance of a zinc finger nuclease with a six amino acid linker. Bioorg Med Chem Lett. 19: 3970-3972
159. Shimizu Y, Şöllü C, Meckler JF, Adriaenssens A, Zykovich A, Cathomen T, Segal DJ. 2011. Adding fingers to an engineered zinc finger nuclease can reduce activity. Biochemistry. 50: 5033-5041
160. Silva G, Poirot L, Galetto R, Smith J, Montoya G, Duchateau P, Pâques F. 2011. Meganucleases and other tools for targeted genome engineering: Perspectives and challenges for gene therapy. Curr Gene Ther. 11: 11-27
161. Smith J, Berg JM, Chandrasegaran S. 1999. A detailed study of the substrate specificity of a chimeric restriction enzyme. Nucleic Acids Res. 27: 674-681
162. Smith J, Bibikova M, Whitby FG, Reddy AR, Chandrasegaran S, Carroll D. 2000. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28: 3361-3369. (Pubitemid 30662302
163. Soldner F, Laganière J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, et al. 2011. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 146: 318-331
164. Stanley P, Narasimhant S, Siminovitch L, Schachtert H. 1975. Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-Activity. Proc Natl Acad Sci USA. 72: 3323-3327
165. Stanley P, Schachter H, Taniguchi N. 2009. N-Glycans. In: Varki A, Cummings R, Esko J, editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. p. 101-114
166. Steentoft C, Bennett EP, Clausen H. 2013. Glycoengineering of human cell lines using zinc finger nuclease gene targeting: Simplecells with homogeneous GalNAc O-glycosylation allow isolation of the O-glycoproteome by one-step lectin affinity chromatography. In: Brockhausen I, editor. Glycosyltransferases, Methods Mol. Biol. New York: Springer. p. 387-402
167. Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager K.T.-B.G, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, et al. 2013. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J. 32: 1478-1488
168. Steentoft C, Vakhrushev SY, Vester-Christensen MB, Schjoldager K.T.-B.G, Kong Y, Bennett EP, Mandel U, Wandall H, Levery SB, Clausen H. 2011. Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines. Nat Methods. 8: 977-982
169. Stoddard BL. 2011. Homing endonucleases: From microbial genetic invaders to reagents for targeted DNA modification. Structure. 19: 7-15
170. Sun N, Zhao H. 2013. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. Biotechnol Bioeng. 111: 1048-1053
171. Syka JEP, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. 2004. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad Sci USA. 101: 9528-9533
172. Takeuchi R, Choi M, Stoddard BL. 2014. Redesign of extensive protein-DNA interfaces of meganucleases using iterative cycles of in vitro compartmentalization. Proc Natl Acad Sci USA. 111: 4061-4066
173. Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA. 2011. Overexpression of GalNAc-Transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene. 30: 4843-4854
174. Ten Hagen KG, Zhang L, Tian E, Zhang Y. 2009. Glycobiology on the fly: Developmental and mechanistic insights from Drosophila. Glycobiology. 19: 102-111
175. Tsuji S, Futaki S, Imanishi M. 2013. Creating a TALE protein with unbiased 5′-T binding. Biochem Biophys Res Commun. 441: 262-265
176. Urnov FD, Miller JC, Lee Y-L, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature. 435: 646-651. (Pubitemid 40825505
177. Vakhrushev SY, Steentoft C, Vester-Christensen MB, Bennett EP, Clausen H, Levery SB. 2013. Enhanced mass spectrometric mapping of the human GalNAc-Type O-glycoproteome with SimpleCells. Mol Cell Proteomics. 12: 932-944
178. Vester-Christensen MB, Halim A, Joshi HJ, Steentoft C, Bennett EP, Levery SB, Vakhrushev SY, Clausen H. 2013. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc Natl Acad Sci USA. 110: 21018-21023
179. Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby Da, et al. 2006. O-linked N-Acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol Cell Proteomics. 5: 923-934. (Pubitemid 43792801
180. Wang T, Wei JJ, Sabatini DM, Lander ES. 2013. Genetic screens in human cells using the CRISPR/Cas9 system. Science. 343: 80-84
181. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 153: 910-918
182. Wefers B, Meyer M, Ortiz O, Hrabé de Angelis M, Hansen J, Wurst W, Kühn R. 2013. Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci USA. 110: 3782-3787
183. Wilson KA, McEwen AE, Pruett-Miller SM, Zhang J, Kildebeck EJ, Porteus MH. 2013. Expanding the repertoire of target sites for zinc finger nucleasemediated genome modification. Mol Ther Nucleic Acids. 2: E88
184. Wong AW, Baginski TK, Reilly DE. 2010. Enhancement of DNA uptake in FUT8-deleted CHO cells for transient production of afucosylated antibodies. Biotechnol Bioeng. 106: 751-763
185. Wright JA. 1973. Evidence for pleiotropic changes in lines of Chinese hamster ovary cells resistant to concanavalin A and phytohemagglutinin-P. J Cell Biol. 56: 666-675
186. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S, et al. 2011. The genomic sequence of the Chinese Hamster Ovary (CHO)-K1 cell line. Nat Biotechnol. 29: 735-741
187. Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, O'Malley P, Nobori S, Vagefi PA, Patience C, et al. 2005. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1, 3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med. 11: 32-34. (Pubitemid 40215834
188. Yamaji T, Hanada K. 2014. Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. PLoS ONE. 9: E88124
189. Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M, Kusunoki M, Iida S, Nakano R, Wakitani M, Niwa R, Sakurada M, Uchida K, et al. 2004. Establishment of FUT8 knockout Chinese Hamster Ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng. 87: 614-622. (Pubitemid 39295406
190. YanW, Smith C, Cheng L. 2013. Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing. Sci Rep. 3: 1-6
191. Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP. 2013. SKK196 is a glycosylationspecific O-mannose kinas required for dystroglycan function. Science. 341: 896-899
192. Yusa K, Rashid ST, Strick-Marchand H, Varela I, Liu P-Q, Paschon DE, Miranda E, Ordóñez A, Hannan NRF, Rouhani FJ, et al. 2011. Targeted gene correction of α1-Antitrypsin deficiency in induced pluripotent stem cells. Nature. 478: 391-394
193. Zhang P, Haryadi R, Chan KF, Teo G, Goh J, Pereira NA, Feng H, Song Z. 2012. Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese Hamster Ovary mutant. Glycobiology. 22: 897-911
194. Zhang L, Lawrence R, Frazier BA, Esko JD. 2006. CHO glycosylation mutants: Proteoglycans. Methods Enzymol. 416: 205-221. (Pubitemid 44750112
195. Zielinska DF, Gnad F, Wiśniewski JR, Mann M. 2010. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell. 141: 897-907
196. Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou B-K, Chen G, Ye Z, Park I-H, Daley GQ, et al. 2009. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 5: 97-110.